X4 Pharmaceuticals, Inc.XFORNASDAQ
Loading
Operating Income Growth Under PressureDecelerating
Percentile Rank0
Studio
Year-over-Year Change

Year-over-year operating income growth rate

Latest
-138.68%
↓ 350% vs avg
Percentile
P0
Near historical low
Streak
1 yr
Consecutive declineDecelerating
Average
-30.85%
Historical baseline
PeriodValue
2025-138.68%
202466.15%
2023-22.79%
2022-2.89%
2021-42.14%
2020-15.80%
2019-12.68%
2018-26.99%
2017-48.41%
2016-64.22%